Insiders Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Real-time Estimate Cboe BZX Other stock markets 10:06:00 10/05/2024 pm IST			5-day change	1st Jan Change
25.92 ^USD	+2.59%		-6.05%	+14.39%

08/05	Transcript : Anika Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024
08/05	Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 EPS $0.09	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Anika Therapeutics, Inc. Announces Management Changes, Effective June 3, 2024	09/05	CI
Anika Therapeutics, Inc. Announces Board Changes	26/02	CI
Anika Therapeutics, Inc. Appoints Anne Nunes as Senior Vice President, Chief Operations Officer	22/23/22	CI
Anika Therapeutics reaches settlement with activist investor Caligan	14/23/14	RE
Anika Therapeutics, Inc. Appoints Gary Fischetti as Class III Director	14/23/14	CI
Caligan pushes ahead with board challenge at Anika, nominates two directors	28/23/28	RE
Caligan pushes ahead with board challenge at Anika, nominates two directors	28/23/28	RE
Insider Buy: Anika Therapeutics	14/22/14	MT
Anika Appoints Sheryl Conley to Board of Directors	01/21/01	CI
Insider Trends: Insider Purchase of Anika Therapeutics Stock Extends 90-Day Positive Trend	13/21/13	MT
Insider Trends: 90-Day Insider Buying Trend at Anika Therapeutics Slowed with Sale of Shares	13/20/13	MT
Anika Therapeutics, Inc. Announces Board Changes	09/20/09	CI
Anika Therapeutics, Inc. Announces Executive Changes, Effective August 10, 2020	06/20/06	CI
Anika Therapeutics, Inc. Announces Resignation of Sylvia Cheung as Chief Financial Officer Effective August 21, 2020	03/20/03	CI
Anika Therapeutics, Inc. Announces Resignation of Sylvia Cheung as Treasurer and Assistant Secretary Effective August 21, 2020	03/20/03	CI
Anika Therapeutics, Inc. Appoints Cheryl R. Blanchard as President and Chief Executive Officer	27/20/27	CI
Anika Therapeutics, Inc. Appoints David Colleran as Executive Vice President, General Counsel and Corporate Secretary	04/20/04	CI
Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO	13/20/13	CI
Anika Therapeutics, Inc. Announces Demise of Joseph Darling, President and Chief Executive Officer	30/20/30	CI
Anika Therapeutics, Inc. Appoints Mira Leiwant as Vice President of Regulatory Affairs, Quality and Clinical Affairs	14/19/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Insiders

Filters